NetworkNewsBreaks

TuesdayApr 18, 2023 12:29 pm

NetworkNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Announces Participation in Upcoming Planet MicroCap Showcase

IGC Pharma (NYSE American: IGC) will be presenting at this month’s Planet MicroCap Showcase: VEGAS 2023; the event is slated for Wednesday, April 26, 2023, at 7:30 p.m. ET. According to the announcement, IGC Pharma CEO Ram Mukunda and principal financial officer Claudia Grimaldi will be hosting the presentation; the session will include time for questions and answers. The live presentation will be available via webcast; a replay of the presentation will be available on the conference event platform. In addition, Mukunda and Grimaldi will be available for one-on-one, in-person meetings, to be held at the conference venue in Las…

Continue Reading

TuesdayApr 18, 2023 12:20 pm

NetworkNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Assay Results for Texmont Property

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), has released assay results that an expansion of high grade, near-surface nickel mineralization at the Texmont property located 36 kilometers south of Timmins, Ontario. According to the announcement, the result are from 16 additional holes with assays pending from 11 holes; the company has drilled a total of 39 holes covering 9,696 meters as part of an exploration program to support the development of a resource. Highlights of the result include the confirmation of high-grade near-surface mineralization with nine drillholes showing intersections of higher-grade (above 1% nickel) mineralization. “The latest assay results continue to confirm…

Continue Reading

TuesdayApr 18, 2023 12:10 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN), EVT Collaborate to Enhance EV Performance, Scale to Other Energy Applications

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a partnership with Global EV Technology, Inc. and EV Technologies, LLC. (collectively “EVT”) to form Mullen Advanced Energy Operations, LLC. (“MAEO”) with initial development for improving energy management technology in electric vehicles for greater range and vehicle performance and scaling to other energy applications. Mullen owns 51% of the newly formed entity and will consolidate the results of its operations in Mullen Automotive. Under the agreement, Global EV Technology will contribute its technology and existing contracts to MAEO, and Mullen will provide capital, execution and commercialization to grow…

Continue Reading

TuesdayApr 18, 2023 11:59 am

NetworkNewsBreaks – RYVYL Inc. (NASDAQ: RVYL) Releases Financial Report for Q4, FY 2022

RYVYL (NASDAQ: RVYL), a company that leverages the security of the blockchain and USD-pegged stablecoin technology with near-real-time attestation to conduct payment transactions, is reporting record full-year revenues in its just-released financial report, which covers the fourth quarter and full year for the period ending Dec. 31, 2022. Highlights of the report included 33% growth in full-year revenue, which totaled $32.9 million on processing volume of $3.6 billion, an 83% increase from $1.95 billion processed in 2021; record Q4 revenue of $11.1 million, a 56% increase over Q4 2021; and FX and international payments business reporting more than $1 billion…

Continue Reading

TuesdayApr 18, 2023 11:47 am

NetworkNewsBreaks – AtomBeam Reports a $1.3M StartEngine Investment

AtomBeam, whose compaction product massively drives efficiency in data transmission and storage, has raised $1.3 million in its current crowdfunding campaign on StartEngine. Calling the milestone a “significant achievement,” the company noted its growing investor community in its efforts, saying that they “recognize the potential of AtomBeam's technology to revolutionize how virtually every machine talks to another machine.” The company’s compaction technology is designed to disrupt how connected machines and the Internet of Things communicate, reducing the amount of data needing to be transmitted by an average of 75% and offering significant cost and efficiency benefits to both businesses and…

Continue Reading

TuesdayApr 18, 2023 11:39 am

NetworkNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Reports FY 2022 Financial Statements, Corporate Update

BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotech company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, published its full-year financial results for the year ended December 31, 2022; the report also included key business updates. Highlights of the report include the signing of definitive agreements with the Max Planck Society (“MPG”) and the University Medical Center Göttingen, Germany (“UMG”) designed to enable BiondVax to build a pipeline of “bio-better” nanosized VHH antibodies (NanoAbs); notice that the unique physicochemical characteristics of NanoAbs being generated by BiondVax’s scientific partners show several competitive attributes,…

Continue Reading

MondayApr 17, 2023 1:22 pm

NetworkNewsBreaks – Prime Harvest Inc. Eyes Continued Growth and Expansion with Recently Launched Reg A+ Offering

Prime Harvest, a tech-focused legal cannabis enterprise and parent company to SoCal’s premier dispensary JAXX Cannabis, recently launched Weed 4 The People – the company’s Reg A+ offering that allows the public to own a piece of the company for as little as $4.20 per share at a minimum of 100 shares. “Prime Harvest aims to raise upwards of $42M to fund the expansion of JAXX Cannabis, the company’s flagship store, and delivery platform. Options for potential investors range from $420 to $50,000+, with rewards that include equity stake in the company, and in-store benefits including instant rebates, cashback incentives,…

Continue Reading

MondayApr 17, 2023 1:10 pm

NetworkNewsBreaks – Progressive Care Inc. (RXMD) Identified as a High-Growth Opportunity

Progressive Care (OTCQB: RXMD) offers services and technology that supports the managed health care industry to reduce costs and improve the quality of care. “The company has been steadily building both its pharmacy and data-management divisions as revenues continue to improve. However, a couple of extremely revealing events recently transpired that may have set the course for considerable upside potential. “The first inkling of something big cooking was revealed in a September press release, which announced that Progressive Care had successfully completed a recapitalization of its debt as well as a strategic investment of $6 million from NextPlat Corp (NASDAQ:…

Continue Reading

MondayApr 17, 2023 12:47 pm

NetworkNewsBreaks – Truleo Reaches $500K in Investments in StartEngine Raise

Body camera analytics company Truleo today announced that its StartEngine raise has just reached $500,000. As the No. 1 provider of automated body camera reviews, Truleo believes that professional police behavior leads to more positive outcomes and that civilians are more willing to comply with the police when there is mutual respect. Truleo’s A.I. technology works by leveraging natural language processing to analyze the audio on an officer’s body camera and determine when conflict-based events may have occurred during a call for service. The officer’s language is then scored as professional or unprofessional. The company is tapping into a massive…

Continue Reading

MondayApr 17, 2023 12:41 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Completes Critical Step in Advancing Lucid-MS Pipeline

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and metabolic disorders. The company today announced completion of the first-in-human (“FIH”) sentinel dosing of Lucid-21-302 (“Lucid-MS”) in its phase I clinical trial evaluating its novel drug candidate as an orally administered treatment for multiple sclerosis (“MS”). “Dosing the sentinel subject is a major achievement for our team and culmination of more than a decade of very promising research by a seasoned development team passionate about changing the future treatment…

Continue Reading